4.7 Article

Investigation of 3D ordered macroporous carbon with different polymer coatings and their application as an oral vaccine carrier

Journal

INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 487, Issue 1-2, Pages 234-241

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2015.04.045

Keywords

3-D ordered macroporous carbon; Chitosan; Polyethyleneimine; Oral immunity; Release rate; Electrostatic attraction

Funding

  1. National Basic Research Program of China (973 Program) [2015CB932100]
  2. National Natural Science Foundation of China [81273449]

Ask authors/readers for more resources

3-D ordered macroporous carbon with different polymer coatings were developed as new oral vaccine immunological systems. Poly dimethyl diallyl ammonium (PDDA), polyethyleneimine (PEI) and chitosan (CTS), three different polymers with electropositive or adsorption-promoting properties, were chosen as the coating materials to endow the vaccine delivery systems with different surface properties. The bovine serum albumin (BSA) was used as a model vaccine. The three different polymer coated systems exhibited similar release rate which minimized the influence of release rate. The measured value of immunoglobulin G (IgG) titers suggested that the sustained release rate of BSA from polymer coated systems exhibited no strengthened effect on the immune response but could delay the appearance of the peak of the IgG titers compared with uncoated system. The electrostatic attraction between the mucosal and positively charged carrier would be useful during the whole immune experiment. In addition, using the coating material with the ability of enhancing mucosal adsorption was important in the mid-late period of immune. The immunoglobulin A (IgA) titers induced by the polymer coated systems were significantly higher than that induced by the oral BSA solution or i.m. BSA with Freund's complete adjuvant (FCA) which suggested the successful mucosal immune response of the three different coated systems. Overall, this work provides valuable information for the development of oral vaccine delivery system. (C) 2015 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available